Pinecrest Investmnt (ACOL) 0.0006 $ACOL Acology

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Pinecrest Investmnt (ACOL) 0.0006 $ACOL

Acology Announces Big 2015/ Better Than Expected Start to 2016
PR Newswire - Mon Mar 07, 8:05AM CST
Acology Inc. (OTC-Pink: ACOL) announced today that sales in the first two months of 2016 have exceeded expectations. The company predicts that estimated transactions for calendar 2016 will be three times greater than the year previous. Gross sales of their signature product, The MedTainer(TM), surpassed 2015 levels for the first two months of the calendar year by 198%. Acology's base grew in 2015 to over 1240 retailers. Acology announced that it finished 2015 with sales advances in excess of 310%. The company had projected that it would end calendar 2015 with $1.4M in total revenues. With the release of the company's 10-K at the end of this month Acology believes it will substantially exceed previous projections. In addition, Acology announced that the results of sales and marketing efforts have increased new business by a factor of three in the preceding twelve-month period.

NACCO Industries, Inc. Announces New Contract Mining Agreement
PR Newswire - Wed Dec 09, 4:05PM CST
NACCO Industries, Inc. (NYSE: NC) announced today that Bisti Fuels Company, LLC, a subsidiary of The North American Coal Corporation, has entered into a 15-year, cost-plus Contract Mining Agreement with Navajo Transitional Energy Company, LLC ("NTEC". Under the agreement, Bisti Fuels will act as NTEC's contract miner at NTEC's Navajo Mine, a surface coal mine located within the Navajo Nation near Fruitland, San Juan County, New Mexico. Production is expected to be approximately 5.9 million tons of coal per year. Pursuant to a separate agreement, NTEC will deliver that coal to the third-party owners of the nearby Four Corners Generating Station. Similar to most of North American Coal's other agreements, the agreement between Bisti Fuels and NTEC is a cost-plus arrangement, under which NTEC will pay Bisti Fuels' costs and a profit margin per ton.
NC: 56.62 (+1.03)

Acology Due Diligence Report: Up 500% in a Week, Then Softening - BrokerBank Securities
PR Newswire - Thu Oct 01, 7:20AM CDT
Acology, Inc. (OTCBB: ACOL) shares closed yesterday at $.0027 off 28.95%. Share volume was at 63 million, about four times the average. The share on September 22nd was $.0007 and had soared to $ .0038 before yesterday's drop.

Acology Records Record Growth
Marketwired - Thu Sep 24, 7:01AM CDT
Acology Inc. (OTCQB: ACOL) and its subsidiary D&C Distributors LLC announces that one of the world's largest gift shops, Bonanza are now carrying souvenir Medtainers in Lv, Nevada as well as Viva Vegas & Las Vegas Souvenirs.

Letter to Shareholders: From Curt Fairbrother, CEO
Marketwired - Tue Sep 15, 7:02AM CDT
Acology Inc. (OTCQB: ACOL)

Acology Inc. Announces Transfer of Convertible Note
Marketwired - Wed Sep 09, 7:03AM CDT
Acology Inc. (OTCQB: ACOL) and its subsidiary D&C Distributors LLC announces that Richard S. Astrom, the holder of ACOL's convertible promissory note in the original principal amount of $400,000, of which $360,000 is outstanding, has transferred the note to a third party. The note was made in favor of Mr. Astrom on March 4, 2014, in connection with the merger through which ACOL acquired D&C. Mr. Astrom and his wife have disposed of all of the 400,000,000 shares of ACOL's common stock that were registered last year under a registration statement that ACOL filed in 2014 and that they held through affiliates. As a result, Mr. Astrom no longer has any involvement with ACOL. CEO Curt Fairbrother states, "We are very pleased to make this announcement and see it as a positive step in moving forward.

NACCO announces retirement of president and CEO of The North American Coal Corporation
M2 - Tue May 19, 9:34AM CDT
NACCO Industries Inc (NYSE:NC) announced on Monday the retirement of Robert L. Benson, president and CEO of NACCO's wholly owned subsidiary, The North American Coal Corporation, on 30 June 2015.
NC: 56.62 (+1.03)

Robert L. Benson to Retire as President and Chief Executive Officer of The North American Coal Corporation
PR Newswire - Mon May 18, 7:33AM CDT
NACCO Industries, Inc. (NC-NYSE) announced today that Robert L. Benson, President and Chief Executive Officer of NACCO's wholly owned subsidiary, The North American Coal Corporation, will retire on June 30, 2015.
NC: 56.62 (+1.03)

Cliffs Natural Resources Inc. Reports First-Quarter 2015 Results
PR Newswire - Tue Apr 28, 3:20PM CDT
Cliffs Natural Resources Inc. (NYSE: CLF) today reported first-quarter results for the period ended March 31, 2015. Revenues were $574 million not considering the revised accounting treatment for North American Coal and the Canadian Entities, as further discussed below. In addition, adjusted EBITDA1 was $94 million. The following table provides a summary of revenues and adjusted EBITDA1 by operating segment.
CLF: 6.10 (+0.16)

Acology Inc. Announces New Interest in Latest-Generation MedTainer
Marketwired - Mon Apr 27, 7:02AM CDT
Acology Inc. (OTCQB: ACOL) and its subsidiary D&C Distributors announced today a substantial upsurge from nation-wide distributors for its signature product, The MedTainer. Citing an internal report, generated at the behest of a nationally-recognized distribution networking organization, Acology has revealed that more than 130 new national distribution points are in the process of being established nationwide to place MedTainers into locations that include drug emporia, convenience stores, package outlets and a host of small retail operations.

Retail Sales Campaign Produces Better-Than-Anticipated Results
Marketwired - Tue Apr 14, 7:03AM CDT
Acology Inc. (OTCQB: ACOL) and its affiliate D&C Distributors announced today that initial results of a new marketing campaign initiated by the Hornung Ad Agency has produced results that have eclipsed the initial projections made by the agency at the beginning of the month. (See Press Release "Acology Inc. Announces Agreement with New Ad Agency/April 6, 2015.) The direct result of marketing efforts to increase awareness of Acology's signature product, The Medtainer, has seen an upsurge of new customer orders.

Acology Inc. Announces New Online Retail Agency Agreement and Launch
Marketwired - Mon Apr 06, 7:01AM CDT
Acology Inc. (OTCQB: ACOL) has announced today that it has completed an agreement with the Jason Hornung Advertising Agency and launched a new, aggressive campaign emphasizing increased internet and E-commerce sales and social media penetration. This new program will enable the company to market its products to all the industries it serves including veterinary, geriatrics, pharmaceutical and the medical cannabis market.

Acology Announces New Advisory Board Member
Marketwired - Wed Jan 28, 7:02AM CST
Acology Inc. (OTCQB: ACOL) is very pleased to announce the addition of Ms. Mieko Hester-Perez to its Advisory Board. Ms. Hester-Perez brings unique qualifications to Acology. In addition to being a board member of NORML's Women's Alliance, Ms. Hester-Perez is the co-founder of the Unconventional Foundation for Autism. (www.UF4A.Org) Ms. Hester-Perez's informational website raises awareness and support for the families of children stricken with this mysterious and misunderstood disease. She will become a spokesperson for Acology on the importance of legally compliant packaging and the effectiveness of Acology products.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 397

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 149

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 205

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 606

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 288

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 196

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 245

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 258

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 223

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 322

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading

Top 5 Most Recently Viewed Articles

Care Synergy and RCC Medical Equipment Launch New Partnership

Updated Category News Views 320

Care Synergy and RCC Medical Equipment Form Joint Venture In an exciting development for healthcare services, Care Synergy and RCC Medical Equipment Co. have announced their plans to create a strategic joint venture aimed at improving healthcare delivery in the Colorado Front Range region. This partnership will leverage the strengths of both organizations to provide...

Continue Reading
Revitalizing China's Tourism with High-Tech Cultural Experiences

Updated Category News Views 217

Revitalizing China's Tourism Through High-Tech Cultural Experiences China's tourism industry is undergoing an exciting transformation, fueled by the innovative use of advanced technology paired with its rich cultural heritage. A remarkable example is in Chongqing Municipality, where the city's skyline has become a vibrant showcase of cultural stories, highlighted by...

Continue Reading
Intriguing Insights into United States Steel Options Trades

Updated Category News Views 111

Analyzing Unusual Options Activity in United States Steel Recently, there's been notable market activity where investors with deep pockets are taking a more bearish stance on United States Steel (X). This trend is definitely something for retail traders to pay attention to, especially when navigating the complexities of the stock market. Today's options history unveiled...

Continue Reading
Mesoblast's Operational Highlights and Financial Insights Unveiled

Updated Category News Views 185

Mesoblast Limited's Webcast for Financial Results On a recent occasion, Mesoblast Limited (NASDAQ: MESO; ASX: MSB), a pioneer in allogeneic cellular medicine for inflammatory diseases, announced a webcast to delve into their operational achievements and financial metrics for the half year concluding December 31, 2024. Details of the Webcast Event The engaging webcast is...

Continue Reading
Investors of DXC Technology Prepare for Class Action Lawsuit

Updated Category News Views 77

Investors of DXC Technology Company Take Action In recent months, investors who purchased common stock from DXC Technology Company (NYSE: DXC) have been given a significant opportunity to participate in a class action lawsuit. This situation arises from allegations of securities fraud that are said to have affected many individuals who bought shares during specific key...

Continue Reading